Stroke/Vascular Neurology News

The American Stroke Association, a division of the American Heart Association, has published a new scientific statement outlining the role of primary care providers in post-stroke care.

Aduhelm should not be used to treat cerebral amyloid angiopathy outside a clinical trial due to “substantial uncertainties and concerns” about the agent’s safety and efficacy, according to correspondence published in The Lancet Neurology.

Vulnerable populations along the U.S. southern border require targeted intervention to improve stroke-related mortality, according to research in the Journal of the American Heart Association.

Following an intracerebral hemorrhage, decreased estimated glomerular filtration rate correlated with poor outcomes, according to study results published in Neurology.

Patients with large vessel occlusion stroke undergoing endovascular thrombectomy who were transferred directly to the angiography suite at admission had faster treatment and better functional outcomes during all hours and treatment windows.

At hospitals participating in Get With the Guidelines-Stroke, patients with acute ischemic stroke received similar quality care and had comparable outcomes before and during the COVID-19 pandemic.

Long-term results from the ASCOT trial demonstrated that an amlodipine-based BP-lowering regimen reduced stroke risk compared with an atenolol-based regimen, although no benefit in dementia risk was observed.

Results of a meta-analysis published in Neurology determined there was no difference in functional outcomes between direct thrombectomy and combination with bridging IV thrombolysis among Asian patients with large vessel occlusion stroke.

A survey of community neurologists demonstrated four primary themes associated with the impact of the COVID-19 pandemic in this group, specifically highlighting “the unusual environment” in which these providers practice.

Younger adults born early preterm experienced up to a 42% greater risk for stroke compared with those born full term, an association not entirely explained by genetic or environmental factors, according to data published in Stroke.